FDA OKs Linagliptin/Metformin Combo for Type 2 DiabetesFDA OKs Linagliptin/Metformin Combo for Type 2 Diabetes
Approval is for the treatment of adults with type 2 diabetes as adjunct to diet and exercise. FDA Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Alert Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Internal Medicine | Metformin | Nutrition | Sports Medicine